About Indegene
Indegene is a company based in Princeton (United States) founded in 1998 by Gaurav Kapoor, Rajesh Bhaskaran Nair, Manish Gupta, Anand Kiran, and Sanjay Suresh Parikh.. Indegene has raised $255.15 million across 4 funding rounds from investors including The Carlyle Group, Syneos Health and Nadathur. The company has 4,490 employees as of March 31, 2024. Indegene has completed 11 acquisitions, including BioPharm Communications, CultHealth and Encima Group. Indegene operates in a competitive market with competitors including Zuellig Pharma, IntegriChain, Fishawack, Clinigen and Science Group, among others.
- Headquarter Princeton, United States
- Employees 4490 as on 31 Mar, 2024
- Founders Gaurav Kapoor, Rajesh Bhaskaran Nair, Manish Gupta, Anand Kiran, Sanjay Suresh Parikh
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Indegene Limited
-
Annual Revenue
$331.66 M (USD)9.64as on Mar 31, 2024
-
Net Profit
$47.55 M (USD)20.79as on Mar 31, 2024
-
EBITDA
$62.85 M (USD)4.53as on Mar 31, 2024
-
Total Equity Funding
$255.15 M (USD)
in 4 rounds
-
Latest Funding Round
$35.15 M (USD), Unspecified
Apr 16, 2021
-
Investors
The Carlyle Group
& 5 more
-
Employee Count
4490
as on Mar 31, 2024
-
Investments & Acquisitions
BioPharm Communications
& 10 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Indegene
Indegene is a publicly listed company on the NSE with ticker symbol INDGN in India, operating in the Commercial services sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Unlock access to complete
Software Development Team
220 people
Leadership Team
83 people
Data Analysis and Operations Team
72 people
Senior Team
69 people
Sales and Marketing
54 people
Product Management Team
33 people
Associate Team
30 people
Lead Team
26 people
Unlock access to complete
Funding Insights of Indegene
Indegene has successfully raised a total of $255.15M across 4 strategic funding rounds. The most recent funding activity was a Unspecified round of $35.15 million completed in April 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 4
- Last Round Unspecified — $35.2M
- First Round First Round
- Investors Count 6
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr, 2021 | Amount | Unspecified - Indegene | Valuation | Ca Dawn Investment Company | |
| Feb, 2021 | Amount | Private Equity Round - Indegene | Valuation |
investors |
|
| Jan, 2020 | Amount | Private Equity Round - Indegene | Valuation | Syneos Health |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Indegene
Indegene has secured backing from 6 investors, including venture fund and institutional investors. Prominent investors backing the company include The Carlyle Group, Syneos Health and Nadathur. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity investments are directed toward multiple sectors.
|
Founded Year | Domain | Location | |
|
Brighton Park Capital is focused on growth equity investments.
|
Founded Year | Domain | Location | |
|
Investments and philanthropy services offered by Nadathur Group.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Indegene
Indegene has strategically engaged in corporate development activities, having acquired 11 companies. Notable acquisitions include BioPharm Communications, CultHealth and Encima Group. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Limited information available
|
2010 | ||||
|
Omni-channel analytics solutions are provided for pharma marketing teams.
|
2006 | ||||
|
Marketing services are provided to pharmaceutical and biopharma companies.
|
2005 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Indegene
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Indegene Comparisons
Competitors of Indegene
Indegene operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Zuellig Pharma, IntegriChain, Fishawack, Clinigen and Science Group, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Healthcare access in Asia is enhanced by Zuellig Pharma.
|
|
| domain | founded_year | HQ Location |
Inventory, order and customer relationship management solution for life science suppliers.
|
|
| domain | founded_year | HQ Location |
Fully integrated cross-border services are delivered to global pharmaceutical organizations.
|
|
| domain | founded_year | HQ Location |
Specialty medicines are supplied via clinical trials and access programs.
|
|
| domain | founded_year | HQ Location |
Technology-based consultancy and product development services are provided.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Indegene
Frequently Asked Questions about Indegene
When was Indegene founded?
Indegene was founded in 1998 and raised its 1st funding round 4 years after it was founded.
Where is Indegene located?
Indegene is headquartered in Princeton, United States. It is registered at Princeton, New Jersey, United States.
Who is the current CEO of Indegene?
Manish Gupta is the current CEO of Indegene. They have also founded this company.
Is Indegene a funded company?
Indegene is a funded company, having raised a total of $255.15M across 4 funding rounds to date. The company's 1st funding round was a Private Equity Round of $20M, raised on Jun 01, 2002.
How many employees does Indegene have?
As of Mar 31, 2024, the latest employee count at Indegene is 4,490.
What is the annual revenue of Indegene?
Annual revenue of Indegene is $331.66M as on Mar 31, 2024.
What does Indegene do?
Indegene was founded in 1998 and is headquartered in Princeton, United States. Operations focus on the healthcare sector, where suite solutions are delivered to payers and providers. Payer offerings include transformation, care management, member acquisition and engagement, healthcare analytics, and Medicare analysis. ACO solutions encompass transformation services, outcomes improvement, patient engagement, and analytics. Cloud-based platforms are operated for customer engagement, member loyalty and retention, and care management.
Who are the top competitors of Indegene?
Indegene's top competitors include Zuellig Pharma, IntegriChain and Clinigen.
Is Indegene publicly traded?
Yes, Indegene is publicly traded on NSE under the ticker symbol INDGN.
How many acquisitions has Indegene made?
Indegene has made 11 acquisitions, including BioPharm Communications, CultHealth, and Encima Group.
Who are Indegene's investors?
Indegene has 6 investors. Key investors include The Carlyle Group, Syneos Health, Nadathur, Karnataka Information Technology Venture Capital Fund, and Brighton Park Capital.
What is Indegene's ticker symbol?
The ticker symbol of Indegene is INDGN on NSE.
What is Indegene's valuation?
The valuation of Indegene is $598.56M as of Apr 2021.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.